Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation

被引:30
|
作者
Aguilar, Eduardo [2 ]
Maria Garcia-Diaz, Ana [3 ]
Sanchez Munoz-Torrero, Juan Francisco [4 ]
Ramon Alvarez, Lorenzo [5 ]
Piedecausa, Mar [6 ]
Arnedo, Gemma [7 ]
Monreal, Manuel [1 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Med Interna Serv, Dept Internal Med, Badalona 08916, Barcelona, Spain
[2] Hosp Alcaniz, Dept Internal Med, Alcaniz, Teruel, Spain
[3] ABS Gaudi, Primary Healthcare, Barcelona, Spain
[4] Hosp San Pedro de Alcantara, Dept Internal Med, Caceres, Spain
[5] Hosp Terrassa, Dept Vasc Surg, Barcelona, Spain
[6] Hosp Gen Univ Elche, Dept Internal Med, Alicante, Spain
[7] Hosp Badalona Germans Trias & Pujol, Dept Vasc Surg, Badalona 08916, Barcelona, Spain
关键词
Atrial fibrillation; Ayocardial infarction; Atroke; Bleeding; Antiplatelets; Anticoagulants; ANTITHROMBOTIC THERAPY; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; PREVENT STROKE; TASK-FORCE; RISK; ASPIRIN; CLOPIDOGREL; MANAGEMENT; WARFARIN;
D O I
10.1016/j.thromres.2012.05.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The influence of atrial fibrillation (AF) on outcome in patients with symptomatic atherosclerotic disease has not been thoroughly studied. Methods: FRENA is an ongoing registry of stable outpatients with coronary (CAD), cerebrovascular (CVD), or peripheral (PAD) artery disease. With the aim to guide therapy, we assessed the incidence of subsequent myocardial infarction (MI), ischemic stroke or major bleeding in patients with AF, according to initial presentation. Results: As of June 2011, 3848 patients were recruited: 1436 had CAD, 1104 CVD, and 1308 had PAD. Of these, 470 (12%) had AF: 151 patients with CAD, 157 with CVD, and 162 with PAD. Over a mean follow-up of 16 +/- 13 months, 19 patients with AF developed acute MI, 22 ischemic stroke and 7 bled. Among AF patients with CAD, the incidence of subsequent MI (5.00 events per 100 patient-years; 95% CI: 2.54-8.91) was non-significantly higher than that of stroke (1.48; 95% CI: 0.38-4.04) or major bleeding (1.47; 95% CI: 0.37-4.01). Among those with CVD, the incidence of stroke (5.61; 95% CI: 2.95-9.75) exceeded that of MI (no events) or major bleeding (0.51; 95% CI: 1.24-6.36). Among those with PAD, the incidence of MI (4.41; 95% CI: 2.15-8.10) and stroke (3.93; 95% CI: 1.82-7.46) were similar. Conclusions: CAD patients with AF are at a higher risk of subsequent MI than of stroke. Among those with CVD, the risk of stroke far exceeds that of MI. Those with PAD have a high and similar risk for both events. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 50 条
  • [21] Real-Life Incident Atrial Fibrillation in Outpatients with Coronary Artery Disease
    Ninni, Sandro
    Lemesle, Gilles
    Meurice, Thibaud
    Tricot, Olivier
    Lamblin, Nicolas
    Bauters, Christophe
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 11
  • [22] Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
    Lee, So-Ryoung
    Jung, Jin-Hyung
    Choi, Eue-Keun
    Lee, Seung-Woo
    Kwon, Soonil
    Park, Ji-Suck
    Kang, Jeehoon
    Han, Kyung-Do
    Park, Kyung Woo
    Oh, Seil
    Lip, Gregory Y. H.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [23] Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
    Cho, Min Soo
    Kang, Do-Yoon
    Ahn, Jung-Min
    Yun, Sung-Cheol
    Oh, Yong-Seog
    Lee, Chang Hoon
    Choi, Eue-Keun
    Lee, Ji Hyun
    Kwon, Chang Hee
    Park, Gyung-Min
    Choi, Hyung Oh
    Park, Kyoung-Ha
    Park, Kyoung-Min
    Hwang, Jongmin
    Yoo, Ki-Dong
    Cho, Young-Rak
    Kim, Ji Hyun
    Hwang, Ki Won
    Jin, Eun-Sun
    Kwon, Osung
    Kim, Ki-Hun
    Park, Seung-Jung
    Park, Duk-Woo
    Nam, Gi-Byoung
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (22): : 2075 - 2086
  • [24] Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry
    Fauchier, Laurent
    Greenlaw, Nicola
    Ferrari, Roberto
    Ford, Ian
    Fox, Kim M.
    Tardif, Jean-Claude
    Tendera, Michal
    Steg, Ph. Gabriel
    PLOS ONE, 2015, 10 (04):
  • [25] Peripheral artery disease and atrial fibrillation
    Parisi, R.
    Bortoluzzi, C.
    Bonanome, A.
    Vescovo, G.
    PROCEEDINGS OF THE 21ST EUROCHAP - IUA EUROPEAN CHAPTER CONGRESS OF THE INTERNATIONAL UNION OF ANGIOLOGY, 2013, : 26 - 27
  • [26] Major bleeding events in stable outpatients with coronary, cerebrovascular or peripheral artery disease: findings from the FRENA registry1
    Gadelha, T.
    Bisbe, J.
    Toril, J.
    Alcala Pedrajas, J. N.
    Monreal, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (08) : 1414 - 1416
  • [27] Cilostazol and outcome in outpatients with peripheral artery disease
    Perez, Paulina
    Esteban, Carlos
    Carles Sauquillo, Joan
    Yeste, Monserrat
    Manzano, Luis
    Mujal, Abel
    Jimenez Caballero, Pedro Enrique
    Aguilar, Eduardo
    Sanchez Munoz-Torrero, Juan Francisco
    Monreal, Manuel
    THROMBOSIS RESEARCH, 2014, 134 (02) : 331 - 335
  • [28] Anemia and Outcome in Outpatients With Peripheral Artery Disease
    Perez, Paulina
    Esteban, Carlos
    Jimenez Caballero, Pedro Enrique
    Sanchez Munoz-Torrero, Juan Francisco
    Pascual Soria, Maria Teresa
    Aguilar, Eduardo
    Alvarez Rodriguez, Lorenzo Ramon
    Carles Sahuquillo, Joan
    Garcia Diaz, Ana Maria
    Monreal, Manuel
    ANGIOLOGY, 2016, 67 (05) : 484 - 489
  • [29] Atrial fibrillation in coronary artery disease
    Lokshyn, S
    Mewis, C
    Kuhlkamp, V
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 72 (02) : 133 - 136
  • [30] Coronary artery disease and atrial fibrillation
    Theodorakis, Georgios N.
    HELLENIC JOURNAL OF CARDIOLOGY, 2017, 58 (03) : 213 - 214